Skip to main content
Advertisement
Advertisement

GMED

GMED logo

GLOBUS MEDICAL INC

74.08
USD
Sponsored
-0.08
-0.11%
Sep 18, 15:59 UTC -4
Closed
exchange

After-Market

74.11

+0.03
+0.03%

GMED Earnings Reports

Positive Surprise Ratio

GMED beat 29 of 43 last estimates.

67%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$808.10M
/
$1.21
Implied change from Q2 26 (Revenue/ EPS)
+2.34%
/
-9.70%
Implied change from Q3 25 (Revenue/ EPS)
+5.08%
/
+2.54%

GLOBUS MEDICAL INC earnings per share and revenue

On Aug 06, 2026, GMED reported earnings of 1.34 USD per share (EPS) for Q2 26, beating the estimate of 1.12 USD, resulting in a 19.50% surprise. Revenue reached 789.61 million, compared to an expected 798.50 million, with a -1.11% difference. The market reacted with a +1.57% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 1.21 USD, with revenue projected to reach 808.10 million USD, implying an decrease of -9.70% EPS, and increase of 2.34% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NANO-X IMAGING LTD Ordinary Shares
Report Date
Sep 09, 2026 For Q2 26
Estimate
-$0.16
Actual
-$0.80
Surprise
-380.19%
FAQ
For Q2 2026, GLOBUS MEDICAL INC reported EPS of $1.34, beating estimates by 19.5%, and revenue of $789.61M, -1.11% below expectations.
The stock price moved up 1.57%, changed from $81.08 before the earnings release to $82.35 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on -- analysts, GLOBUS MEDICAL INC is expected to report EPS of $1.21 and revenue of $808.10M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement